WASHINGTON—Medtech association AdvaMed announced Robery Cohen will be the next chair of its Digital Health Tech board of directors. Cohen is the vice president of innovation and technology of the orthopaedic group at Stryker.He succeeds Dr. Taha Kass-Hout, global chief science and technology officer at GE HealthCare, who served as the inaugural chair of the board overseeing the then-newly created division.
Cohen will serve a two-year term beginning this month.
“We’re thrilled to have Robert Cohen as our new board chair,” said Shaye Mandle, executive director of the AdvaMed Digital Health Tech division. “Robert’s leadership and expertise in digital health will be critical to the success of our members as we continue to shape the policy landscape for access and adoption of the most innovative digital health technologies. We also want to celebrate Taha Kass-Hout for his service as the inaugural DHT board chair. Taha’s leadership has been invaluable to the DHT division, AdvaMed, and the success of our members.”
AdvaMed announced the formation of its Digital Health Tech division in October 2023. The division represents digital health companies, medtech companies with a significant digital component and big tech companies with health care products and services. The division and the establishment of the Medical Imaging Technology division announced in December 2023 ensure AdvaMed represents the entire ecosystem of the medtech, digital health tech and medical imaging companies providing high tech, interconnected solutions to serve patients.
“Policy conversations in our nation’s capital increasingly center on digital health tech,” said Scott Whitaker, AdvaMed president and CEO. “In congress and the executive branch, policymakers and regulators see technology as a solution for personalized care, better patient outcomes, reaching under-served patients and increasing health care affordability. We’re fortunate to have leaders of the Digital Health Tech division board who are expertly equipped to explain the continuously iterating tech innovations available to serve patients. Thank you to Taha, for two years of exemplary service as our first-ever DHT board chair, and to Robert for his willingness to serve. I’m looking forward to a transformational two years.”
“Without question, digital innovation is transforming the medtech industry,” Cohen said. “It will lead to improved outcomes and create new market opportunities. Advancing digital health in life sciences is exciting, and it is quickly accelerating. As the AdvaMed Digital Health Tech board chair, I am privileged to collaborate with accomplished leaders across our board and membership who share the passion for the amazing potential of digital health to transform patient care. Our Digital Health Tech board focus will continue to be to assure policy and regulation do indeed enable a better future for health care.”